Compare NRXP & KG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRXP | KG |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | Bermuda |
| Employees | 29 | 44 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.2M | 87.3M |
| IPO Year | N/A | N/A |
| Metric | NRXP | KG |
|---|---|---|
| Price | $3.73 | $9.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $38.25 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 5.2K |
| Earning Date | 05-14-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,547.84 | N/A |
| Revenue Next Year | $1,591.73 | N/A |
| P/E Ratio | ★ N/A | $1.38 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.65 | $8.07 |
| 52 Week High | $5.06 | $31.45 |
| Indicator | NRXP | KG |
|---|---|---|
| Relative Strength Index (RSI) | 48.47 | 36.58 |
| Support Level | $3.45 | $9.39 |
| Resistance Level | $3.84 | $12.30 |
| Average True Range (ATR) | 0.32 | 0.83 |
| MACD | -0.09 | -0.17 |
| Stochastic Oscillator | 45.00 | 0.32 |
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Kestrel Group Ltd specializes in providing fronting services to insurance program managers, MGAs, reinsurers, and reinsurance brokers with two reportable segments: Program Services and Legacy Reinsurance. The Group facilitates insurance transactions utilizing its management contracts with four insurance carriers. Its line business includes casualty, workers' compensation, catastrophe-exposed property, and non-catastrophe-exposed property, with diverse risk durations, sizes, and product types.